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DObjective: Two different strategies have emerged in the initial palliation for hypoplastic left heart syndrome, the
conventional Norwood operation and the so-called hybrid procedure. We have used each of these at our center.
The purpose of the present study was to compare the outcomes of both procedures.
Methods: From 2007 to 2012, 40 patients presented to the Cardinal Glennon Children’s Medical Center with
hypoplastic left heart syndrome or 1 of its variants. Of the 40 patients, 24 underwent a hybrid procedure and
16 a Norwood procedure for initial palliation. The medical records, echocardiograms, and cardiac catheteriza-
tion data were retrospectively reviewed. Standard statistical analysis was performed.
Results: The patients who underwent the hybrid procedureweighed less than thosewho underwent the Norwood
procedure. Overall unadjusted survival was better in the Norwood group, although this did not reach statistical
significance. Overall hospital resource usage was similar in both cohorts, taking into account both first and
second palliation stages.
Conclusions: In our review, we found no statistically significant difference in survival or resource usage
between those patients undergoing the Norwood procedure and those undergoing a hybrid procedure as initial
palliation for hypoplastic left heart syndrome. (J Thorac Cardiovasc Surg 2014;147:1777-82)The palliation for hypoplastic left heart syndrome (HLHS)
has evolved into 2 staged surgical strategies to achieve an
unobstructed systemic outflow tract, unrestricted intra-
atrial communication, a controlled source of pulmonary
blood flow, and a reliable source of coronary blood flow.
Currently, the Norwood operation can achieve these goals,
with a 30-day mortality of 11.5% in average risk patients.1
However, neonates with associated prematurity, an intact
atrial septum, severe valve insufficiency, a low birth weight
(<2.5 kg), noncardiac conditions, or genetic abnormalities
are considered high-risk candidates with a reported stage I
hospital mortality of 40% to 60%.2
For these high-risk patients with HLHS, an alternative
hybrid strategy was developed, consisting of stenting of
the ductus arteriosus and banding the branch pulmonary ar-
teries, with encouraging early results.3 This procedure
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The Journal of Thoracic and Carreconstruction, deferring these procedures to stage II palli-
ation (SIIP) at 4 to 6 months of age when such high-risk pa-
tients theoretically can tolerate a longer and more complex
operation. Some centers have adopted this strategy for
initial palliation in all patients with HLHS. However,
important potential disadvantages of the hybrid technique
at the first stage include retrograde arch obstruction from
the ductal stent, resulting in coronary and cerebral malper-
fusion; restrictive intra-atrial communication, resulting in
early and late pulmonary venous obstruction; and early
and late mechanical distortion of the branch pulmonary ar-
teries, resulting in an imbalance of systemic and pulmonary
blood flow and injury to the branch pulmonary arteries.
Each of these disadvantages can profoundly inhibit the
achievement of a total cavopulmonary connection and
long-term survival.
The purpose of the present report was to retrospectively
compare our results with both strategies, including our
learning curve, with an emphasis on unadjusted early and
midterm survival, hemodynamics, pulmonary artery (PA)
growth, morbidity, and time-related resource usage.METHODS
Patients
We conducted a retrospective review of 40 consecutive patients with
HLHS or 1 of its variants who had undergone staged single ventricle palli-
ation with either a hybrid (n ¼ 24) or Norwood (n ¼ 16) strategy from
January 2007 to December 2012. The institutional review boards of St
Louis University and Cardinal Glennon Children’s Medical Center
approved the study and waived the need for patient consent. The analysis
excluded any patients enrolled in either an interim strategy for heartdiovascular Surgery c Volume 147, Number 6 1777
Abbreviations and Acronyms
HLHS ¼ hypoplastic left heart syndrome
SIP ¼ stage I palliation
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Dtransplantation or a bridge to 2-ventricle repair. No patient in the Norwood
group underwent an emergent salvage operation.
The decision regarding initial surgical palliation varied during the study
period. For the first 1.5 years of the study, all patients, without exception,
underwent a Norwood procedure. For the subsequent 2 years, all patients,
without exception, underwent a hybrid procedure. In the final 1.5 years of
the study, the pathway of surgical palliation was decided during an interdis-
ciplinary conference attended by representatives from cardiology, cardiac
surgery, and critical care on an individual patient basis.
The demographic information, cardiac anatomy, hemodynamics and
echocardiographic variables, and all postoperative outcomes were recorded
retrospectively from the patient medical records. The families, cardiolo-
gists, and primary care pediatricians were interviewed as necessary to
gather complete follow-up information.
Echocardiography was performed at admission, before discharge after
stage I palliation (SIP) and before SIIP, before discharge after SIIP, and
at the latest follow-up examination. Pulmonary insufficiency was graded
according to established criteria as follows: trace to mild, 0; mild, 1;
moderate, 2; severe, 3.4 Cardiac catheterization was performed to assess
the hemodynamic variables before SIIP in all patients.
The follow-up data were complete for 26 hospital survivors and not
significantly different between the 2 cohorts (hybrid group, 741  725
days; Norwood group, 524  530 days; P<.31).
Early death was defined as death in the operating room, in the hospital
postoperatively, or within 30 days of surgery, regardless of discharge status.
Death after discharge or>30 days after the procedure was considered late.
Interstage death was defined as death occurring after discharge from SIP
hospitalization and before SIIP.
The day of surgery was the first recorded day for the hospital stay, inten-
sive care unit stay, and intubation period. For patients not discharged
between SIP and SIIP, the total interstage duration in days was used as
the hospital stay after SIP. The duration of continuous intubation included
patients reintubated within 24 hours of extubation. Reintervention at any
time included any cardiac reoperation, diaphragm plication, a transcatheter
procedure for recurrent coarctation, the development of a restrictive atrial
septum, and PA or shunt stenosis. The patient demographic profile, cardiac
morphology, and diagnosis are summarized in Table 1.
Surgical Management
Norwood procedure. Norwood palliation included sternotomy and
right atrial and innominate artery cannulation with a polytetrafluoroethy-
lene (Gore-Tex, W. L. Gore & Associates, Inc, Flagstaff, Ariz) graft,
with hypothermia to 18C. After ductal division, the distal aortic arch
was augmented 5 to 10 mm beyond the insertion of the ductus arteriosus
using a homograft patch with the heart beating and full brain perfusion dur-
ing core cooling. The proximal arch reconstruction and PA to ascending
aorta amalgamation (Damus-Kaye-Stansel) and atrial septectomy were
performed with the heart arrested and regional cerebral perfusion at 40
to 45 mL/kg/min. The modified Blalock-Taussig shunt (3 patients) or poly-
tetrafluoroethylene (Gore-Tex, W. L. Gore & Associates, Inc) right ventric-
ular to PA conduit (13 patients) was inserted with the heart beating during
rewarming after atrial closure, cardiac air removal, and systemic reperfu-
sion in accordance with published techniques. The type of systemic to pul-
monary shunt used was decided by the surgeon and chosen in accordance
with what surgeon thought was best suited for the anatomy. Dopamine,1778 The Journal of Thoracic and Cardiovascular Surmilrinone, epinephrine, and delayed sternal closure were used postopera-
tively in selected patients. Phenoxybenzamine was not used in any patient.
SIIP consisted of bidirectional cavopulmonary anastomosis in all pa-
tients. Bidirectional Glenn and PA reconstruction were performed with
the heart beating, and cardioplegia was used for repeat atrial septectomy
or repair of the tricuspid valve. Regional cerebral perfusion through the
innominate artery and cardioplegia were used when patch enlargement of
the neo-aorta or coarctation site was required. A left superior vena cava
was routinely anastomosed to the left PA. The patch material was either
a pulmonary homograft or autologous pericardium.
Hybrid Procedure
SIP was performed according to the technique previously described by
Galantowicz and colleagues.5 PA banding used a segment of 3.0- or
3.5-mm polytetrafluoroethylene (Gore-Tex, W. L. Gore & Associates,
Inc) tube wrapped around each branch PA. Surface echocardiography
was used to assess the band tightness, with a goal velocity of 3 to 4 m/s.
Balloon atrial septostomywas performed as a separate procedure, and atrial
stents were not used. SIIP was performed in accordance with previously
published techniques.6 The aortic arch augmentation after stent removal
and atrial septectomy used regional cerebral perfusion, as described for
the Norwood procedure. During rewarming, with the heart beating, the
distal main PA was reconstructed with a homograft, the right PA was
augmented at the band site with the cavopulmonary anastomosis, and the
left PAwas balloon dilated intraoperatively.
Modified ultrafiltration was used in all patients after each operation. No
patient in either cohort crossed over. Our home interstage monitoring
program, as described by Ghanayem and colleagues,7 was applied equally
to all patients.
Statistical Analysis
Theoutcomeswere tabulatedusing an intent-to-treat analysis.Continuous
data are presented as the median and range and mean standard deviation,
as appropriate. The categorical characteristics are given as counts and per-
centages and were compared using Fisher’s exact test or the chi-square
test, as appropriate. Two group comparisons of continuous variables and out-
comes were compared using unpaired 2-tailed t tests. Late outcomes are
expressed in a time-dependent manner using Kaplan-Meier analysis and
were compared using a log-rank test. All analyses were performed using
the Statistical Package for Social Sciences (SPSS, Inc, Chicago, Ill).
RESULTS
Patient Profile and Anatomy
The demographic and morphologic characteristics of the
2 cohorts are summarized in Table 1. The mean age of the
hybrid cohort was older, but the hybrid patients had a signif-
icantly lower weight, with a greater proportion weighing
<2.5 kg. The frequency of aortic atresia and the morpho-
logic subtypes of HLHS were comparable, with a nearly
equal distribution of coexisting anatomic lesions.
Perioperative and Interstage Data
Stage I. At completion of SIP, the right and left band veloc-
ity was similar in the hybrid group and the discharge oxygen
saturations were similar between the 2 cohorts. The overall
postintervention extracorporeal membrane oxygenation
requirement was low but showed a trend toward being
greater in the Norwood group (Table 2).
Interstage hemodynamics. The hemodynamic evaluation
before SIIP occurred at a mean of 5 months in both cohortsgery c June 2014
TABLE 1. Patient characteristics
Characteristic Hybrid (n ¼ 24) Norwood (n ¼ 16) P value
Demographics
Male gender 16 (68) 8 (50) .29
Age at SIP (d) 10  7 6  2 .03
Weight at SIP (kg) 2.6  0.7 3.1  0.5 .03
Weight<2.5 kg 11 (46) 1 (6) .01
Genetic syndrome 4 (17) 0 (0) .10
Morphology
HLHS
AA/MA 6 (25) 3 (19) .72
AA/MS 4 (17) 4 (25) .69
AS/MA 1 (4) 1 (6) 1.00
AS/MS 9 (37) 3 (19) .69
Aortic atresia 10 (42) 7 (44) .89
Unbalanced AVC 2 (8) 0 (0) .51
Double outlet RV 2 (8) 0 (0) .51
Double inlet LV 2 (8) 3 (19) .63
Coexisting anatomy
VSD 2 (8) 2 (12) 1.00
TAPVR 2 (8) 1 (6) 1.00
Intact atrial septum 1 (4) 1 (3) 1.00
Heterotaxy 1 (4) 0 (0) 1.00
Dextrocardia 1 (4) 0 (0) 1.00
IAA 0 (0) 1 (6) 1.00
Data presented as mean standard deviation or n (%). SIP, Stage I palliation; HLHS,
hypoplastic left heart syndrome; AA/MA, aortic atresia/mitral atresia; AA/MS, aortic
atresia/mitral stenosis; AS/MA, aortic stenosis/mitral atresia; AS/MS, aortic stenosis/
mitral stenosis; AVC, atrioventricular canal; RV, right ventricle; LV, left ventricle;
VSD, ventricular septal defect; TAPVR, total anomalous pulmonary venous return;
IAA, interrupted aortic arch.
TABLE 2. Perioperative data at SIP and SIIP
Variable Hybrid Norwood P value
SIP
CPB time (min) NA 167  54
Crossclamp time (min) NA 63  42
PA band velocity
RPA (m/s) 3.7  0.5 NA
LPA (m/s) 3.8  0.6 NA
Discharge SaO2 (%) 86  4 83  6 .16
ECMO 1 (4) 2 (13) .6
Interstage hemodynamics
Age (d) 131  43 130  46 .93
Aortic saturation (%) 71  6 68  5 .20
Superior caval saturation (%) 52  3 47  8 .15
RVEDP (mm Hg) 10  1 10  3 .4
Qp/Qs 1.3  0.08 0.72  0.35 .03
Mean PA (mm Hg) 15  6 15  2 .75
SIIP
Age (d) 161  32 151  40 .44
CPB time (min) 217  33 89  32 .001
Crossclamp time (min) 116  29 0 NA
Latest SaO2 (%) 81  6 82  4 .65
ECMO 0  0 1 (8) 1.0
Data presented as n (%), median, or mean  standard deviation. SIP, Stage I pallia-
tion; SIIP, stage II palliation; CPB, cardiopulmonary bypass; PA, pulmonary artery;
RPA, right pulmonary artery; LPA, left pulmonary artery; SaO2, oxygen saturation;
ECMO, extracorporeal membrane oxygenation; RVEDP, right ventricle end-
diastolic pressure; Qp/Qs, pulmonary blood flow/systemic blood flow ratio; NA, not
applicable.
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approximately 70% from the SIP levels of approximately
80%. We can infer that single ventricular function was
well preserved in both groups because of the low end-
diastolic pressure and similar superior caval oxygen satura-
tions. In the hybrid patients, band tightness would seem to
have remained adequate because of the relatively low
mean distal PA pressure. However, the pulmonary-
to-systemic flow ratio was significantly greater in the hybrid
patients, although the PA pressures and ventricular end-
diastolic pressureswere nearly the same. Thiswould suggest
lower pulmonary vascular resistance in the hybrid group.
Stage II palliation. SIIP occurred at a mean of approxi-
mately 5 months of age in the hybrid and Norwood patients
(Table 2). The cardiopulmonary bypass and global myocar-
dial ischemic times were significantly greater in the hybrid
group than in their Norwood counterparts, as would be
expected given the differences in the operations. At the
latest follow-up point, the peripheral oxygen saturation
had remained similar in all patients.Reintervention
A total of 32 reinterventions were performed in 20 pa-
tients (hybrid, 11 of 24, 46%; Norwood, 9 of 16, 50%;The Journal of Thoracic and CarP ¼ .5) during the entire study (Table 3). No patient
required a separate readmission to the hospital for these in-
terventions. Some were performed during the pre-SIIP car-
diac catheterization. Of the 17 transcatheter interventions, 5
(29%) involved stenting residual coarctation after the Nor-
wood procedure, and 5 hybrid patients required balloon and
stent intervention on the left PA (3 patients) or vein (1 pa-
tient, twice). The most frequent surgical reintervention
was insertion of a modified Blalock-Taussig shunt. Two
hybrid patients developed discontinuous left PA (before
routine use of intraoperative balloon dilatation) and
required PA rehabilitation with a systemic shunt. Both pa-
tients successfully underwent completion Fontan, 1 to a sin-
gle lung. A hybrid patient with total anomalous pulmonary
venous return required Glenn takedown at SIIP and died late
of gastrointestinal bleeding. A second patient with severe
tricuspid regurgitation required urgent Glenn takedown af-
ter hybrid SIIP. Late survival was accomplished with staged
valve repair followed by conversion back to a Glenn shunt.
The remaining Blalock-Taussig shunt was inserted into a
Norwood patient with early obstruction of the Sano shunt.Resource Usage
After SIP, resource usage was greater for the Norwood
patients, shown by the significantly longer ventilation and
intensive care unit times and a trend toward longer overalldiovascular Surgery c Volume 147, Number 6 1779
TABLE 3. Resource usage
Variable
SIP SIIP SIP and SIIP
Hybrid Norwood P value Hybrid Norwood P value Hybrid Norwood P value
Intubation time (d) 6 10 .07 6 1 .2 9 12 .31
ICU stay (d) 10 16 .01 16 5 .001 23 21 .9
Hospital stay (d) 19 25 .1 24 8 .01 47 31 .4
Data presented as median values. The patients who died in the hospital were not included in these data. SIP, Stage I palliation; SIIP, stage II palliation; ICU, intensive care unit.
Congenital Heart Disease Brescia et al
C
H
Dhospitalization (Table 3). Comprehensive SIIP for patients
enrolled in the hybrid strategy, requiring stent removal
and aortic arch and PA reconstruction, not surprisingly
required a longer intensive unit care and hospital stay,
with a trend toward a longer ventilator time. However, the
analysis of the combined resource usage for SIP plus SIIP
revealed no significant overall differences in intubation
time or intensive care unit and hospital stay, whether the
original treatment strategy chosen was a hybrid or Norwood
operation.
Follow-up Evaluation
Hybrid patients retained ‘‘band physiology’’ with ductal
stenting, and the main PA and pulmonary valve were quite
dilated. However, their pulmonary valve remained compe-
tent, and the valve annulus and sinotubular ridge diameters
were not significantly different from those in the patients
who underwent a Norwood strategy at late follow-up. The
echocardiographically measured PA diameters were similar
between the 2 cohorts, suggesting that band site reconstruc-
tion of the left PA using intraoperative balloon dilatation
and of the right PA with a Glenn anastomosis is effective
in the early term (Table 4).
Mortality
Mortality after SIP. Eight patients died in the hospital af-
ter SIP (hybrid, 7 of 24, 29%; Norwood, 1 of 16, 6%;
P ¼ .1). The single Norwood mortality occurred from he-
modynamic compromise 4 days after shunt revision.
Among the hybrid cohort, 4 deaths occurred at 20, 30, 35,
and 37 days secondary to necrotizing enterocolitis in 3 or
liver failure in 1. Two patients had Alagille syndrome,
and one had been born with an intact atrial septum. Their
mean weight was 2.0 kg, with an adequate right and left
PA band velocity of 3.5 m/s by echocardiography. TwoTABLE 4. Latest echocardiographic assessment of pulmonary artery
dimensions
Variable Hybrid Norwood P value
Pulmonary insufficiency (%) 0.5  0.6 0.5  .8 .9
LPA diameter* 0.8  1.1 0.7  1.4 .9
RPA diameter* 1.4  1.0 1.0  1.2 .3
Pulmonary valve annulus diameter* 1.5  1.0 2.1  0.8 .1
Sinotubular ridge diameter (mm) 16  4 16  2 .9
Data presented expressed as mean standard deviation. LPA, Left pulmonary artery;
RPA, right pulmonary artery. *Standard deviation of z-score.
1780 The Journal of Thoracic and Cardiovascular Suradditional hybrid deaths (mean weight, 1.8 kg) occurred
at 1 and 16 days secondary to post-transfusion hyperkale-
mia. The remaining hybrid mortality occurred at 85 days
in a patient with trisomy 18 after support was withdrawn
secondary to sepsis and the need for reintubation.
Mortality after SIIP. The 2 hospital deaths after SIIP were
in the hybrid cohort (hybrid, 2 of 17, 12%; Norwood, 0 of
15, 0%; P ¼ .5). One patient with Pierre-Robin syndrome
died on day 11 of low cardiac output and family denial
for mechanical support. The remaining death occurred 27
days after SIIP secondary to aspiration pneumonia and
generalized sepsis.
Late mortality. Four patients (hybrid, 2; Norwood, 2) died
late postoperatively at 72, 122, 134, and 773 days after SIIP
secondary to gastrointestinal bleeding, ventricular fibrilla-
tion at home, viral pneumonia, and severe ventricular fail-
ure while awaiting transplantation, respectively.
The cumulative unadjusted survival (hybrid, 13 of 24,
54%; Norwood, 13 of 16, 81%; P < .08) and 1-year
Kaplan-Meier actuarial survival (hybrid, 58%; Norwood
81%; P<.11) showed a trend toward being greater in the
Norwood cohort, but the difference was not significant
(Figure 1). Given the low mortality rate in the Norwood
group and small sample size, a logistic regression modelFIGURE 1. Graph showing 1-year survival stratified by procedure.
gery c June 2014
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not possible. The groups were not equivalent.We conducted
a special analysis in which we matched the hybrid and Nor-
wood patients by age. In that sample, all statistically signif-
icant differences in the demographics between the 2 groups
were eliminated, and we found no differences in the cumu-
lative survival between the 2 groups (12 of 16 hybrid, 13 of
16 Norwood; P ¼ 1.0).
DISCUSSION
The treatment of HLHS has progressed from comfort
care only (with essentially 100% mortality) to aggressive
reconstructive surgery (with 15% mortality) at most major
pediatric medical centers during the past 25 years. The
introduction of a variety of modifications in the surgical
techniques and refinements in postoperative care were pri-
marily responsible for this improvement. However, contro-
versies remain concerning the precise nature of the initial
palliation for these patients, in particular, for those deemed
to be high risk. The present review of our series of patients
who had undergone either the hybrid or Norwood procedure
was an attempt at validating which strategy would be more
appropriate for patients with HLHS.
The hybrid procedure has been touted as a safer approach
because cardiopulmonary bypass, myocardial ischemia,
and circulatory arrest will be avoided in the newborn.5
The hybrid procedure has been the procedure of choice in
some centers but has been reserved for high-risk patients
in others.8 It is not clear that the hybrid procedure is a safer
approach than conventional reconstructive surgery as initial
palliation in either group.9 The study by Pizarro and col-
leagues9 found no differences in the survival of patients un-
dergoing the hybrid procedure compared with those
undergoing the conventional Norwood operation. Theirs
was not a randomized study, but all patients were deemed
‘‘high risk’’ on the basis of the preoperative characteristics
and were similar in most parameters. Venugopal and col-
leagues8 reported on their experience with the hybrid proce-
dure for 21 patients deemed at high risk for the Norwood
operation. They had an overall mortality of 38%. This
was similar to the mortality reported for the Norwood oper-
ation in high-risk patients at 2 different centers.10,11 Thus,
regarding the survival benefit, it remains unclear whether
the hybrid procedure has an advantage compared with the
conventional Norwood procedure.
The mortality from our series was significantly greater in
the hybrid group. However, the hybrid patients as a group
had greater risk (Table 1). Admittedly, all deaths occurred
in patients considered high risk using previously defined
risk factors, primarily low birth weight. The cause of death
for most of these patients appeared to be related to low sys-
temic cardiac output owing to persistent pulmonary overcir-
culation, presumably the underlying cause of necrotizing
enterocolitis and liver failure seen in our patients.The Journal of Thoracic and CarNecrotizing enterocolitis has been more common after the
hybrid procedure than after the Norwood operation.12,13
Again, it has been presumed that this results from the
relatively lower systemic cardiac output in the hybrid
group than in the Norwood group. In our series, the
pulmonary to systemic blood flow was significantly
greater in the hybrid patients at pre-SIIP cardiac catheteri-
zation. Whether this played a role in the development of
necrotizing enterocolitis in our patients at a point much
earlier in their course is hypothetical. However, we are con-
cerned about this possibility. This speaks to the difficulty in
adjusting the PA bands in small infants in the hybrid cathe-
terization laboratory, where a consistently steady state is not
always achievable. It is also consistent with the findings that
the early postoperative hemodynamic profile of the hybrid
patients was not significantly improved compared with
that seen with patients undergoing the Norwood
procedure.14
The reintervention rate in those patients undergoing the
hybrid procedure was relatively high. In our series, the per-
centage of patients requiring reintervention was similar in
each group. After the hybrid procedure, the most common
reintervention has been for a restrictive atrial septum in pre-
vious studies.3,15 However, this was not seen in our series.
We had a policy of delaying the initial intervention on
the atrial septum, as suggested by Galantowicz and
colleagues.5 We included only those patients requiring
this intervention beyond the first atrial septostomy, regard-
less of when it was performed. The most common reinter-
vention in the Norwood group was for repeat coarctation,
occurring in 31%. This is a typical incidence according to
previously reported series.16,17 All the stents used have
the ability for postdilation to adult size. This can be done
in 2 to 3 future catheterizations, 1 of which could be at
the pre-Fontan evaluation.
Regardless of the initial palliation, both groups of pa-
tients required significant resources during the first year
of life. The intensive care unit stay was significantly shorter
in the hybrid group after SIP but much longer after SIIP. The
differences overall, for both stages, were not significant.
It can be somewhat difficult to accurately measure the PA
size using echocardiography. Nonetheless, we found little
difference between the 2 cohorts in terms of the diameter
of each branch PA. The pulmonary valve annulus size
also was not significantly different between the 2 groups.
We had concerns about the enlargement of the pulmonary
valve annulus and the main PA at SIIP in the hybrid group.
In our early follow-up period, additional significant dilata-
tion did not occur. Likewise, the incidence of pulmonary
valve insufficiency was not different between the 2 cohorts.
The limitations in the present analysis included non-
randomized, retrospective data acquisition, no defined pro-
spective institutional protocol to select patients for either
treatment strategy, and the effect of a learning curve ondiovascular Surgery c Volume 147, Number 6 1781
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cated our study had a 45% power to detect the observed dif-
ferences in SIP mortality. The sample provided a 79%
power to detect twofold differences in the mean length of
stay between the 2 groups; however, the observed difference
was only 50% greater in the Norwood group. Although the
method and management protocols were standardized, it is
possible that individual differences among the physicians
and surgeons could have influenced the patient outcomes.
When we embarked on the present review, we believed
that the 2 groups of patients would be similar because of
the early pattern of strategy used (consistent Norwood pro-
cedure in the initial phase and consistent hybrid procedure
in the middle phase). However, this did not prove true
when the latest group of patients was added, in which
smaller infants were more consistently referred for the
hybrid procedure. Obviously, this would complicate any
conclusions that might be drawn from our retrospective
review.
This brings us back to the original question. Which of
these procedures can provide the best initial palliation for
HLHS? Although we found a trend for the hybrid proce-
dure to result in greater mortality than the Norwood pro-
cedure, the 2 cohorts were not equal in risk, and a
definitive answer cannot be derived from our findings.
Even the high-risk group had somewhat poor outcomes
that were similar to what has been reported in published
studies for the Norwood procedure in high-risk patients.9
The most recent report from the Congenital Heart Surgery
Society of Thoracic Surgeons Database was also some-
what sobering regarding survival after the hybrid proce-
dure for HLHS—26.5% mortality at SIP and 19.8% at
SIIP. No details were available regarding patient selec-
tion. Likely, some patients would benefit from this
approach, such as those listed for transplantation, those
with a borderline left ventricle and aortic stenosis, and
those with a left ventricular tumor causing inflow and
outflow obstruction, with reason to believe that the tumor
will regress. Because of the potential problems with stent
removal at more definitive therapy, some have advocated
banding the PAs and continuing to treat these patients
with prostaglandin E1. This strategy adds yet another
facet to the options available for patients with HLHS.
Much like the study comparing the ‘‘Sano’’ shunt and
the Blalock-Taussig shunt for the Norwood procedure, a
randomized trial controlling for many of the variables
encountered with these patients will be required to1782 The Journal of Thoracic and Cardiovascular Suradequately answer the question regarding which approach
for initial palliation will be most efficacious.
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